Davis Capital Management

Position in AMGN — Amgen Inc

CIK 1811806 JACKSONVILLE, FL

Position in AMGN

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$2,361,384

+$40,230 QoQ

Shares Held

6,521

-1.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

2.49%

of 13F equity value

Holder Rank

#1,188

of 3,140 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Davis Capital Management holds $6,297,182 across 10 Drug Manufacturers - General names. AMGN ranks #2 (37.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	9,856	$2,503,128
2	AMGN	Amgen Inc This page	6,521	$2,361,384
3	ABBV	AbbVie Inc.	5,302	$1,334,195
4	LLY	ELI LILLY & Co	61	$73,165
5	GILD	Gilead Sciences, Inc.	80	$10,107
6	MRK	Merck & Co., Inc.	58	$7,453
7	BMY	Bristol Myers Squibb Co	59	$3,399
8	PFE	Pfizer Inc	137	$3,298

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,361,384	6,521	-1.2%	Shares	Sole	2026-07-16
2026-03-31	$2,321,154	6,597	+1.2%	Shares	Sole	2026-04-16
2025-12-31	$2,134,061	6,520	-0.0%	Shares	Sole	2026-01-28
2025-09-30	$1,840,790	6,523	+6.2%	Shares	Sole	2025-10-21
2025-03-31	$1,914,474	6,145	+3.6%	Shares	Sole	2025-04-11
2024-12-31	$1,545,595	5,930	+1.5%	Shares	Sole	2025-01-17
2024-09-30	$1,881,706	5,840	+0.8%	Shares	Sole	2024-10-01
2024-06-30	$1,809,397	5,791	+1.1%	Shares	Sole	2024-07-02
2024-03-31	$1,629,153	5,730	+1.4%	Shares	Sole	2024-04-05
2023-12-31	$1,627,024	5,649	+26800.0%	Shares	Sole	2024-02-14
2020-06-30	$4,953	21	0.0%	Shares	Sole	2020-07-29
2020-03-31	$4,257	21	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.